Sanofi SNY
NASDAQ SNY
$42.72 -0.13 (-0.30%)
As of: Sep 10, 2026 · 3:59 PM EDT

Sanofi (SNY) Interest Coverage Ratio (2009 - 2026)

Sanofi's (SNY) quarterly Interest Coverage Ratio came in at 3.65 in Q2 2026, up 63.37% year-over-year from 2.23 in Q2 2025, and up 69.38% quarter-over-quarter from 11.92 in Q1 2026.

Analysis

Sanofi (SNY) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Sanofi has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 3.65 for Q2 2026.

  • In Q2 2026, Interest Coverage Ratio rose 63.37% year-over-year to 3.65; the TTM figure through Jun 2026 stood at 3.58 (up 24.07% YoY), while the FY2025 annual figure was 11.27, up 266.72% from the prior year.
  • Interest Coverage Ratio came in at 3.65 for Q2 2026 at Sanofi, up from 11.92 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 8.52 in Q4 2025 to a low of 27.24 in Q1 2022.
  • Average Interest Coverage Ratio over 5 years is 10.37, with a median of 10.41 recorded in 2023.
  • The largest YoY upside for Interest Coverage Ratio was 1695.54% in 2025 against a maximum downside of 118.43% in 2025.
  • Over 5 years, Interest Coverage Ratio stood at 15.24 in 2022, then jumped by 64.68% to 5.38 in 2023, then surged by 90.08% to 0.53 in 2024, then surged by 1695.54% to 8.52 in 2025, then tumbled by 142.82% to 3.65 in 2026.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 3.65 in Q2 2026, 11.92 in Q1 2026, and 8.52 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 25.41
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 10.28
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 3.65
7 Revolution Medicines 42.88 Bn 42.88 Bn - -21.24
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1,199.14
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 114.07
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 52.24
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.65
Mar 31, 2026 -11.92
Dec 31, 2025 8.52
Sep 30, 2025 -12.55
Jun 30, 2025 -9.96
Mar 31, 2025 -10.73
Dec 31, 2024 -0.53
Sep 30, 2024 -13.88
Jun 30, 2024 -4.56
Mar 31, 2024 -5.00
Dec 31, 2023 -5.38
Sep 30, 2023 -10.10
Jun 30, 2023 -9.20
Mar 31, 2023 -14.66
Dec 31, 2022 -15.24
Sep 30, 2022 -26.45
Jun 30, 2022 -14.18
Mar 31, 2022 -27.24
Dec 31, 2021 -18.01
Sep 30, 2021 -34.85